NCT00755196View on ClinicalTrials.gov

Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Psoriasis
Interventions
DRUG

AN2728

AN2728 Ointment, 5%, twice daily for 12 weeks

DRUG

Ointment vehicle

Ointment vehicle, twice daily for 12 weeks

Trial Locations (1)

06700

IMIC, Mexico City

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00755196 - Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis | Biotech Hunter | Biotech Hunter